Literature DB >> 27366404

The Effect of BIS Usage on Anaesthetic Agent Consumption, Haemodynamics and Recovery Time in Supratentorial Mass Surgery.

İclal Karaca1, Fatma Eren Akçıl2, Özlem Korkmaz Dilmen2, Güniz Meyancı Köksal2, Yusuf Tunalı2.   

Abstract

OBJECTIVE: In this study, we aimed to compare Bispectral Index (BIS) monitoring with the conventional anaesthesia approach based on haemodynamic changes in terms of anaesthetic agent consumption, haemodynamic recordings, recovery time and cost.
METHODS: This study was performed in 82 patients, aged 20 to 60 years, who were operated for supratentorial mass and were graded ASA I or II. Cases were randomly divided into two equal groups. In the standard control group haemodynamic parameters were used to determine depth of anaesthesia and in the BIS group, BIS monitoring was applied. In the BIS group the BIS values were kept between 40 and 60; in the control group haemodynamic changes within the range of +/-20% of initial values were controlled using appropriate anaesthetic practice. Haemodynamic parameters, awakening conditions and drug usage were recorded.
RESULTS: The difference between the two groups in terms of timing of eye opening and initial spontaneous breath was not statistically significant. The 'Aldrete' score at the 20(th) postoperative minute for the BIS group was significantly higher than the score calculated for the control group (p<0.05). Rocuronium consumption (mg kg(-1) hr(-1)) was significantly lower in the BIS group than the control group (p<0.05). Although a statistically significant difference (p<0.05) was found between the two groups in terms of initial heart rate and SpO2 values, there was no clinically significant difference in other haemodynamic parameters.
CONCLUSION: Although using BIS monitoring to evaluate depth of anaesthesia does not bring much benefit versus the use of haemodynamic parameters, it may be beneficial for selected surgeries such as awake craniotomy, for patients with a history of awareness and in haemodynamically unstable patients.

Entities:  

Keywords:  BIS monitoring; depth of anaesthesia; haemodynamics; neurosurgery

Year:  2014        PMID: 27366404      PMCID: PMC4894218          DOI: 10.5152/TJAR.2014.24892

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  15 in total

1.  [Bispectral index monitoring is useful to reduce total amount of propofol and to obtain immediate recovery after propofol anesthesia].

Authors:  Takako Masuda; Hirohide Yamada; Kaori Takada; Yasufumi Sagata; Mikiyo Yamaguchi; Yoshinobu Tomiyama; Shuzo Oshita
Journal:  Masui       Date:  2002-04

2.  [The utility of bispectral index monitoring in general anesthesia].

Authors:  R Tufano; R Palomba; G Lambiase; L G Giurleo
Journal:  Minerva Anestesiol       Date:  2000-05       Impact factor: 3.051

3.  The effect of remifentanil on the bispectral index change and hemodynamic responses after orotracheal intubation.

Authors:  B Guignard; C Menigaux; X Dupont; D Fletcher; M Chauvin
Journal:  Anesth Analg       Date:  2000-01       Impact factor: 5.108

4.  Comparison of closed-loop controlled administration of propofol using Bispectral Index as the controlled variable versus "standard practice" controlled administration.

Authors:  M M Struys; T De Smet; L F Versichelen; S Van De Velde; R Van den Broecke; E P Mortier
Journal:  Anesthesiology       Date:  2001-07       Impact factor: 7.892

5.  Bispectral index monitoring in sevoflurane and remifentanil anesthesia. Analysis of drugs management and immediate recovery.

Authors:  S Paventi; A Santevecchi; E Metta; M G Annetta; V Perilli; L Sollazzi; R Ranieri
Journal:  Minerva Anestesiol       Date:  2001-06       Impact factor: 3.051

6.  Bispectral index-guided general anesthesia in combination with thoracic epidural analgesia reduces recovery time in fast-track colon surgery.

Authors:  Jochen Mayer; Joachim Boldt; Alexander Schellhaass; Björn Hiller; Stefan W Suttner
Journal:  Anesth Analg       Date:  2007-05       Impact factor: 5.108

7.  Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial.

Authors:  P S Myles; K Leslie; J McNeil; A Forbes; M T V Chan
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

8.  Bispectral index-guided anaesthesia for off-pump coronary artery bypass grafting.

Authors:  Kanchi Muralidhar; Sanjay Banakal; Keshav Murthy; Rajneesh Garg; G Radhika Rani; R Dinesh
Journal:  Ann Card Anaesth       Date:  2008 Jul-Dec

9.  Narcotrend monitoring allows faster emergence and a reduction of drug consumption in propofol-remifentanil anesthesia.

Authors:  Sascha Kreuer; Andreas Biedler; Reinhard Larsen; Simone Altmann; Wolfram Wilhelm
Journal:  Anesthesiology       Date:  2003-07       Impact factor: 7.892

10.  Hemodynamic and bispectral index changes following skull pin attachment with and without local anesthetic infiltration of the scalp.

Authors:  Parmod Kumar Bithal; Mihir Prakash Pandia; Rajender Singh Chouhan; Deepak Sharma; Hemant Bhagat; Hari Hara Dash; Rajni Arora
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

View more
  4 in total

Review 1.  Anaesthesiologist's Approach to Awake Craniotomy.

Authors:  Onur Özlü
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-08-01

Review 2.  Bispectral index for improving anaesthetic delivery and postoperative recovery.

Authors:  Yodying Punjasawadwong; Aram Phongchiewboon; Nutchanart Bunchungmongkol
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

3.  Bispectral index for improving intraoperative awareness and early postoperative recovery in adults.

Authors:  Sharon R Lewis; Michael W Pritchard; Lizzy J Fawcett; Yodying Punjasawadwong
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26

4.  Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial.

Authors:  Timea Bocskai; Csaba Loibl; Zoltan Vamos; Gabor Woth; Tihamer Molnar; Lajos Bogar; Laszlo Lujber
Journal:  BMC Anesthesiol       Date:  2018-07-28       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.